Immunoassay of insulin-like growth factor-binding protein-3 (IGFBP-3): New means to quantifying IGFBP-3 proteolysis

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 6, 2000, Pages 2327-2333

  Diamandi, Anastasia ^a   Mistry, Jehangir ^b   Krishna, Radha G ^b   Khosravi, Javad ^a,c,d  

^a Diagnostic Systems Laboratories   (Canada)

^b Diagnostic Systems Laboratories Inc   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED PROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; SOMATOMEDIN BINDING PROTEIN 3; THROMBIN;

ADULT; AMNION FLUID; ANTIBODY DETECTION; ARTICLE; COLORIMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MALE; MEASUREMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SEMINAL PLASMA;

EID: 0034456913     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.6.6616     Document Type: Article

References (46)

1. Insulin-like growth factor binding proteins: Structural and molecular relationships
2. Physiologic and cllinical relevance of the insulin-like growth factor binding proteins
3. Insulin-like growth factors and their binding proteins: Biological actions
4. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
5. Insulin-like growth factor binding proteins: A proposed supperfamily
6. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
7. Insulin-like growth factor binding proteins: New proteins, new functions
8. Editorial: Growth inhibition by insulin-like growth factor (IGF) binding protein-3-what's IGF got to do with it
9. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene
10. The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblasts growth factor on mouse fibroblasts with a targeted disruption of the type-1 IGF receptor gene
11. Insulin-like growth factor-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β on programmed cell death through a p53- and IGF-independent mechanisms
12. IGF-independent regulation of breast cancer growth by IGF binding proteins
13. Insulin-like growth factor binding protein (IGFBP) proteases: Functional regulations of cell growth
14. Editorial: IGF binding protein-3 protease regulation: How sweet it is
15. Evidence of enzymatic degradation of insulin-like growth factor binding proteins (IGFBPs) in the 150 K complex during pregnancy
16. Insulin-like growth factor binding proteins (IGFBPs) in maternal serum throughout gestation and in puerperium: Effects of pregnancy-associated serum protease activity
17. Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy
18. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma
19. The heparin binding domain of insulin-like growth factor binding protein (IGFBP)-3 increases susceptibility of IGFBP-3 to proteolysis
20. Proteolysis of insulin-like growth factor binding protein-3 in serum from pregnant, non-pregnant and fetal rats by matrix metalloproteinases and serine proteases
21. Active and inhibitory components of the insulin-like growth factor binding protein-3 protease system in adult serum, interstitial, and synovial fluid
22. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
23. Insulin-like growth factor-I and new opportunities for cancer prevention
24. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
25. Insulin-like growth factor-I and prostate cancer risk: A population-based, case control study
26. Serum insulin-like growth factor-I levels and prostate cancer risk-interpreting the evidence
27. Circulating IGF-I: New perspectives for a new century
28. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A
29. A simple assay for proteolysis of IGFBP-3
30. Research assays for the insulin-like growth factor binding protein proteases
31. ELISA for proteolysis of human insulin-like growth factor binding protein-3 (IGFBP-3): Application to seminal plasma protease activity
32. Ultrasensitive immunoassay for prostate-specific antigen based on conventional colorimetric detection
33. Synthesis of IGFBP-3 fragments in a baculovirus system and characterization of monoclonal anti-IGFBP-3 antibodies
34. The high molecular weight insulin-like growth factor binding protein complex: Epitope mapping, immunoassay, and preliminary clinical evaluation
35. A non-competitive ELISA for human serum insulin-like growth factor-I
36. Immunoassay of insulin-like growth factor binding protein-1
37. Acid-labile subunit of human insulin-like growth factor binding protein complex: Measurement, molecular and clinical evaluation
38. A non-competitive immunoenzymatic assay for insulin-like growth factor binding protein-3 in serum
39. Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3
40. Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine
41. Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequence and relationships between structure and biological activity
42. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) proteolysis in patients with colorectal cancer: Possible association with the metastatic potential of the tumor
43. Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: Discrepancies between radioimmunoassay and ligand blotting
44. Identification of insulin-like growth factor-binding prtein-3 (IGFBP-3) fragments and IGFBP-5 proteolytic activity in human seminal plasma: A comparison of normal and vasectomized patients
45. Proteolysis of insulin-like growth factor-binding protein-3 in the male reproductive tract
46. IGFBP-3 proteolysis by plasmin, thrombin, serum. Heparin binding, IGF binding, and structure of fragments